GlassScriptPhysician profile
Steven Tai
NPI 1790193894
$25,152.14
in general payments reported to CMS, 2019-2025
83 companies · $6,261 in 2025
The $6,261 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,572 · 2022: $4,438 · 2023: $4,722 · 2024: $6,158 · 2025: $6,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Long Term Medical Supply Or Device Loan: $1,332 · Education: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,537.87 |
| Long Term Medical Supply Or Device Loan | $1,331.80 |
| Education | $1,271.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,734.60 | 2021-2025 | |
| Pfizer INC. | $1,464.45 | 2021-2025 | |
| Incyte Corporation | $1,177.62 | 2021-2025 | Jakafi, Monjuvi, Pemazyre |
| Astrazeneca Pharmaceuticals LP | $1,094.80 | 2021-2025 | Calquence, Lynparza, Tagrisso |
| Merck Sharp & Dohme LLC | $1,050.23 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $1,050.23 | 2021-2025 | Imbruvica, Erleada, Carvykti |
| Eisai INC. | $957.11 | 2021-2025 | |
| Celgene Corporation | $770.21 | 2021-2025 | Reblozyl, Pomalyst, Opdivo |
| Astellas Pharma US INC | $763.53 | 2021-2025 | Xtandi, Vyloy, Padcev |
| Daiichi Sankyo INC. | $661.92 | 2021-2025 | Enhertu, Datroway, Vanflyta |
| Glaxosmithkline, LLC. | $657.23 | 2021-2025 | Jemperli, Ojjaara, Zejula |
| Abbvie INC. | $652.90 | 2021-2025 | |
| Exelixis INC. | $622.50 | 2021-2025 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $608.02 | 2021-2025 | Opdivo, Opdualag, Eliquis |
| Sobi, INC | $560.76 | 2021-2025 |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $547.44 | 2021-2025 | Xpovio |
| Lilly USA, LLC | $526.46 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Amgen INC. | $509.17 | 2021-2023 | Lumakras, Blincyto, Kyprolis |
| Pharmacyclics LLC, An Abbvie Company | $497.62 | 2021-2023 | Imbruvica, Epkinly |
| Boehringer Ingelheim Pharmaceuticals, INC. | $420.53 | 2021-2025 | Gilotrif |
| Takeda Pharmaceuticals U.S.A., INC. | $400.00 | 2021-2025 | Alunbrig, Iclusig, Ninlaro |
| Bayer Healthcare Pharmaceuticals INC. | $387.51 | 2021-2025 | |
| Beigene USA, INC. | $378.63 | 2022-2025 | Brukinsa, Tevimbra |
| Gilead Sciences, INC. | $362.62 | 2021-2025 | Trodelvy |
| Adaptive Biotechnologies Corporation | $340.16 | 2022-2025 | Clonoseq |
| Genzyme Corporation | $322.27 | 2021-2025 | |
| Seagen INC. | $272.60 | 2021-2025 | Tukysa |
| Regeneron Healthcare Solutions, INC. | $252.75 | 2024-2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $243.85 | 2021-2024 | Onivyde, Somatuline Depot |
| Puma Biotechnology, INC. | $229.95 | 2022-2025 | |
| Aveo Pharmaceuticals, INC. | $221.47 | 2021-2025 | |
| Genentech USA, INC. | $217.46 | 2023-2025 | Tecentriq, Polivy, Tecentriq Hybreza |
| Sun Pharmaceutical Industries INC. | $202.77 | 2024-2025 | |
| Array Biopharma INC | $188.78 | 2022-2024 | Braftovi, Mektovi, Tukysa |
| Rigel Pharmaceuticals, INC. | $173.47 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Pharmaessentia USA Corporation | $146.83 | 2022-2025 | Besremi |
| Genmab U.S., INC. | $146.65 | 2023-2025 | Epkinly |
| Jazz Pharmaceuticals INC. | $131.97 | 2022-2024 | |
| Cti Biopharma Corp. | $130.64 | 2023 | Vonjo |
| Biohaven Pharmaceuticals, INC. | $122.64 | 2021 | |
| Stemline Therapeutics INC. | $118.90 | 2024-2025 | Orserdu |
| Immunogen, INC. | $101.43 | 2023-2024 | Elahere, Elahere |
| Beone Medicines USA, INC. | $97.46 | 2025 | Brukinsa |
| Immunocore Limited | $92.83 | 2023-2024 | Kimmtrak |
| Servier Pharmaceuticals LLC | $87.13 | 2021-2022 | |
| Taiho Oncology, INC. | $84.05 | 2021-2025 | |
| Recordati_rare_diseases_inc. | $82.48 | 2025 | Enjaymo |
| Emd Serono, INC. | $77.31 | 2024-2025 | |
| Shield Therapeutics INC | $74.73 | 2023-2025 | Accrufer |
| Geron Corporation | $74.29 | 2025 | Rytelo |
| Blueprint Medicines Corporation | $67.21 | 2021-2024 | Ayvakit |
| Alexion Pharmaceuticals, INC. | $64.78 | 2022-2025 | Ultomiris |
| Kyowa Kirin, INC. | $64.63 | 2021-2025 | Poteligeo |
| Tempus Ai, INC | $55.87 | 2024-2025 | Xt Cdx |
| Janssen Pharmaceuticals, INC | $55.07 | 2023-2024 | Xarelto |
| Acrotech Biopharma INC. | $50.48 | 2024-2025 | Beleodaq |
| Coherus Oncology, INC. | $45.99 | 2025 | Loqtorzi |
| Sumitomo Pharma America, INC. | $44.14 | 2025 | Orgovyx |
| Emmaus Medical, INC. | $44.00 | 2021-2023 | Endari |
| Agios Pharmaceuticals, INC. | $38.96 | 2023-2025 | Pyrukynd |
| Syndax Pharmaceuticals, INC. | $34.38 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $34.00 | 2021 | |
| Kite Pharma, INC. | $33.80 | 2021 | |
| Dova Pharmaceuticals | $32.33 | 2021 | |
| Verity Pharmaceuticals INC. | $30.02 | 2025 | Trelstar |
| Adc Therapeutics America, INC. | $29.01 | 2024 | |
| Deciphera Pharmaceuticals INC. | $24.51 | 2024 | Qinlock |
| Boston Scientific Corporation | $24.09 | 2024 | |
| Fennec Pharmaceuticals, INC. | $23.97 | 2024 | Pedmark |
| Myovant Sciences INC. | $23.73 | 2021 | |
| Progenics Pharmaceuticals, INC. | $22.99 | 2024 | |
| Morphosys, US INC. | $22.85 | 2021 | |
| G1 Therapeutics, INC. | $22.25 | 2022 | |
| Caris Mpi, INC. | $21.48 | 2025 | Mi Cancer Seek |
| Foundation Medicine, INC. | $20.96 | 2023 | Foundationone Liquid Cdx |
| Ge Healthcare | $20.32 | 2021 | |
| Iovance Biotherapeutics, INC. | $18.40 | 2025 | Amtagvi |
| Novocure INC. | $16.73 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $15.62 | 2024 | Sancuso |
| Organon LLC | $15.54 | 2023 | Ontruzant |
| Acceleron Pharma, INC. | $15.24 | 2021 | |
| Chiesi USA, INC. | $14.33 | 2024 | Ferriprox |
| Myriad Genetic Laboratories, INC. | $13.50 | 2021 |
Drugs and devices associated with these payments
Kisqali $1,709Keytruda $766Imbruvica $732Lenvima $646Epkinly $572Calquence $526Enhertu $416Opdivo $356Reblozyl $339Jaypirca $335Jakafi $327Lynparza $316Clonoseq $313Vonjo $305Verzenio $301Xtandi $301Brukinsa $270Libtayo $253Elrexfio $246Adcetris $235Gilotrif $225Elahere $219Tukysa $215Odomzo $203Yonsa $203Onivyde $198Xpovio $197Orgovyx $193Talzenna $190Fotivda $189Erleada $184Doptelet $183Jemperli $181Scemblix $176Pluvicto $171Monjuvi $166Cabometyx $158Bosulif $158Pomalyst $153Carvykti $153Ibrance $152Darzalex $148Trodelvy $141Tecentriq $140Tavalisse $133Rezlidhia $133Inlyta $130Besremi $130Stivarga $128Vitrakvi $128Nubeqa $125Braftovi $124Mektovi $124Retevmo $120Orserdu $119Fabhalta $115Tecvayli $112Ojjaara $109Pemazyre $109Alunbrig $108Padcev $107Iclusig $104Opdualag $101Ninlaro $95.96Welireg $95.54Kimmtrak $92.83Besponsa $89.25Talvey $86.43Enjaymo $82.48Zepzelca $82.02Nerlynx $79.90Lorbrena $77.29Accrufer $74.73Rytelo $74.29Datroway $72.93Mekinist $70.47Zynyz $57.25Somatuline Depot $56.97Rybrevant $56.58Xt Cdx $55.87Bavencio $55.59Polivy $55.29Xarelto $55.07Sarclisa $54.56Beleodaq $50.48Zejula $49.80Akeega $49.60Balversa $49.60Loqtorzi $45.99Ultomiris $44.48Xofigo $42.95Ayvakit $40.50Poteligeo $39.12Pyrukynd $38.96Eliquis $38.20Paxlovid $36.05Cerezyme $30.12Cerdelga $30.12Trelstar $30.02Keytruda Qlex $29.94
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Tai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.